EUVIMEDEUVIMED entdecken
Crossref

Asherman syndrome in adenomyosis treated with uterine artery embolization: incidence predictive factors

Yaguang Wang, Weifu Lyu, Wencui Xu, Yongqiang Yu

La radiologia medica · 2020-05 · 125 (5) · 437-443

DOI: 10.1007/s11547-020-01136-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift La radiologia medica, online erschienen am 04.02.2020. Verfasst von Yaguang Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital, Anhui Medical University, 218 Jixi Street, Hefei, 230022, PA, People's Republic of China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To investigate Asherman syndrome (AS) related to potential factors during uterine artery embolization (UAE) treatment of adenomyosis. MATERIALS AND METHODS: This is a retrospective analysis of 195 women with adenomyosis who underwent UAE treatment from 2009 to 2016. All preoperative and intraoperative risk-related potential factors of AS were recorded. And AS events were carefully monitored during follow-up (range, 0-15 months). Potential risk-related factors of AS events were determined via univariate and multivariate logistic regression analyses. RESULTS: The rate of AS events after UAE for adenomyosis was 12.82% (25/195). The univariate and multivariate analyses revealed the association of low vascularity with a significant risk for AS (P = 0.019). CONCLUSION: Patients with low vascularity of adenomyosis at the time of UAE are more likely to have AS. And adenomyosis patients with low vascularity should be carefully selected to undergo UAE treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenomyosisAdultAnalysis of VarianceAngiography, Digital SubtractionEndometriumFemaleFollow-Up StudiesGynatresiaHumansMiddle AgedOrgan SizeRetrospective StudiesRisk FactorsSyndromeUterine Artery EmbolizationUterusYoung Adult

Stichwörter der Autor:innen

AdenomyosisAngiographyAsherman syndromeUAE

Autor:innen und Institutionen

  • Department of Radiology, The First Affiliated Hospital, Anhui Medical University, 218 Jixi Street, Hefei, 230022, PA, People's Republic of China.
  • Department of Radiology, Women and Children Health Care Hospital Affiliated Hospital, Anhui Medical University, 15 Yimin Street, Hefei, 230022, PA, People's Republic of China.
  • Department of Radiology, The First Affiliated Hospital, University of Science and Technology of China, 17 Lujiang Street, Hefei, 230022, PA, People's Republic of China.
  • Department of Radiology, The First Affiliated Hospital, Anhui Medical University, 218 Jixi Street, Hefei, 230022, PA, People's Republic of China. csirwyg85@yeah.net.

Zitieren

APA

Wang, Y., Lyu, W., Xu, W., & Yu, Y. (2020). Asherman syndrome in adenomyosis treated with uterine artery embolization: incidence predictive factors. La radiologia medica, 125(5), 437-443. https://doi.org/10.1007/s11547-020-01136-8

Vancouver

Wang Y, Lyu W, Xu W, Yu Y. Asherman syndrome in adenomyosis treated with uterine artery embolization: incidence predictive factors. La radiologia medica. 2020;125(5):437-443. doi:10.1007/s11547-020-01136-8

BibTeX
@article{Wang2020,
  author = {Wang, Yaguang and Lyu, Weifu and Xu, Wencui and Yu, Yongqiang},
  title = {Asherman syndrome in adenomyosis treated with uterine artery embolization: incidence predictive factors},
  journal = {La radiologia medica},
  year = {2020},
  volume = {125},
  number = {5},
  pages = {437--443},
  doi = {10.1007/s11547-020-01136-8}
}
Kostenlos starten →